Psychostimulants influence oxidative stress and redox signatures: the role of DNA methylation

References

• Hansford B. UNODC World Drug Report 2021: pandemic effects ramp up drug risks, as youth underestimate cannabis dangers. 2021 Jun 24; 2021:1.
   Google Scholar
• Cyr AR, Domann FE. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxidants Redox Signal. 2011;15:551–89. doi:10.1089/ars.2010.3492.
   PubMed Web of Science ®Google Scholar
• Trivedi M, Deth R. A redox/methylation hypothesis of drug addiction. Front Neurosci. 2014;8:1–14. doi:10.3389/fnins.2014.00444.
   PubMedGoogle Scholar
• Adibhatla RM, Hatcher JF. Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2010;12:125–69.
   PubMed Web of Science ®Google Scholar
• Yamamoto BK, Raudensky J. The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol. 2008;3:203–17. doi:10.1007/s11481-008-9121-7.
   PubMed Web of Science ®Google Scholar
• Berríos-Cárcamo P, Quezada M, Quintanilla ME, et al. Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules. Antioxidants. 2020;9:1–26. doi:10.3390/antiox9090830.
   Web of Science ®Google Scholar
• Nielsen DA, Utrankar A, Reyes JA, et al. Epigenetics of drug abuse: predisposition or response. Pharmacogenomics. 2012;13:1149–60.
   PubMed Web of Science ®Google Scholar
• Sivalingam K, Doke M, Khan MA, et al. Influence of psychostimulants and opioids on epigenetic modification of class III histone deacetylase (HDAC)-sirtuins in glial cells. Sci Rep. 2021;11:1–16. doi:10.1038/s41598-021-00836-z.
   PubMed Web of Science ®Google Scholar
• Mahna D, Puri S, Sharma S. Dna methylation signatures: biomarkers of drug and alcohol abuse. Mutat Res Mutat Res. 2018;777:19–28.
   PubMed Web of Science ®Google Scholar
• Ciccarone D. Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Prim Care Clin Off Pract. 2011;38:41–58.
   PubMed Web of Science ®Google Scholar
• Trivedi M, Shah J, Hodgson N, et al. Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake. Mol Pharmacol. 2014;85:747–57. doi:10.1124/mol.114.091728.
   PubMed Web of Science ®Google Scholar
• Doke M, Pendyala G, Samikkannu T. Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes. PLoS One. 2021;16:e0252895.
   PubMed Web of Science ®Google Scholar
• Limanaqi F, Gambardella S, Biagioni F, et al. Epigenetic effects induced by methamphetamine and methamphetamine-dependent oxidative stress. Oxid Med Cell Longev. 2018;2018; doi:10.1155/2018/4982453.
   PubMed Web of Science ®Google Scholar
• Wei H, Liang F, Meng G, et al. Redox_methylation mediated abnormal DNA methylation as regulators of ambient fine particulate matter-induced neurodevelopment related impairment in human neuronal cells _ Enhanced Reader.pdf n.d.
   Google Scholar
• Miller CA, Campbell SL, Sweatt JD. Dna methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity. Neurobiol Learn Mem. 2008;89:599–603.
   PubMed Web of Science ®Google Scholar
• Miller CA, Gavin CF, White JA, et al. Cortical DNA methylation maintains remote memory. Nat Neurosci. 2010;13:664–6.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Offer SM. Epigenetic regulations of GABAergic neurotransmission: relevance for neurological disorders and epigenetic therapy. Med Epigenetics. 2016;4:1–19. doi:10.1159/000444713.
   Google Scholar
• Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common µ1 opioid receptor mechanism. Science. 1997;276:2048–50.
   PubMed Web of Science ®Google Scholar
• Kuepper R, Morrison PD, van Os J, et al. Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplines. Schizophr Res. 2010;121:107–17.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Loonam TM NOAILLESP, Angulo JA. Comparison of cocaine-and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions. Ann N Y Acad Sci. 2001;937:93–120.
   PubMed Web of Science ®Google Scholar
• Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid-induced respiratory depression. Br J Pharmacol. 2021.
   PubMed Web of Science ®Google Scholar
• Volkow ND, Fowler JS, Wang G-J, et al. Dopamine in drug abuse and addiction. Arch Neurol. 2007;64:1575. doi:10.1001/archneur.64.11.1575.
   PubMed Web of Science ®Google Scholar
• Daniel E Shumer NJNNPS. 乳鼠心肌提取 HHS Public access. Physiol Behav. 2017;176:139–48. doi:10.1111/ejn.14130.Targeting.
   PubMedGoogle Scholar
• Muratore CR, Hodgson NW, Trivedi MS, et al. Age-dependent decrease and alternative splicing of methionine synthase mRNA in human cerebral cortex and an accelerated decrease in autism. PLoS One. 2013;8:e56927.
   PubMed Web of Science ®Google Scholar
• Trivedi M, Zhang Y, Lopez-Toledano M, et al. Differential neurogenic effects of casein-derived opioid peptides on neuronal stem cells: implications for redox-based epigenetic changes. J Nutr Biochem. 2016;37:39–46.
   PubMed Web of Science ®Google Scholar
• Durmaz A, Dikmen N. Homocysteine effects on cellular glutathione peroxidase (GPx-1) activity under in vitro conditions. J Enzyme Inhib Med Chem. 2007;22:733–8.
   PubMed Web of Science ®Google Scholar
• Weiss N, Heydrick SJ, Postea O, et al. Influence of hyperhomocysteinemia on the cellular redox state–impact on homocysteine-induced endothelial dysfunction 2003.
   Google Scholar
• Uys JD, Mulholland PJ, Townsend DM. Glutathione and redox signaling in substance abuse. Biomed Pharmacother. 2014;68:799–807.
   PubMed Web of Science ®Google Scholar
• Cunha-Oliveira T, Cristina Rego A, Oliveira C R. Oxidative stress and drugs of abuse: an update. Mini Rev Org Chem. 2013;10:321–34.
   Web of Science ®Google Scholar
• Himi T, Ikeda M, Yasuhara T, et al. Role of neuronal glutamate transporter in the cysteine uptake and intracellular glutathione levels in cultured cortical neurons. J Neural Transm. 2003;110:1337–48.
   PubMed Web of Science ®Google Scholar
• Chen Y, Swanson RA. The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. J Neurochem. 2003;84:1332–9.
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Tang M-X, Shea S, et al. Plasma homocysteine levels and risk of Alzheimer disease. Neurology. 2004;62:1972–6.
   PubMed Web of Science ®Google Scholar
• Zhu H, Wicker NJ, Shaw GM, et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab. 2003;78:216–21.
   PubMed Web of Science ®Google Scholar
• Ryter SW, Kim HP, Hoetzel A, et al. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9:49–89.
   PubMed Web of Science ®Google Scholar
• Marinelli M, Cooper DC, Baker LK, et al. Impulse activity of midbrain dopamine neurons modulates drug-seeking behavior. Psychopharmacology (Berl). 2003;168:84–98.
   PubMed Web of Science ®Google Scholar
• Xi Z-X, Newman AH, Gilbert JG, et al. The novel dopamine D 3 receptor antagonist NGB 2904 inhibits cocaine’s rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats. Neuropsychopharmacology. 2006;31:1393–405.
   PubMed Web of Science ®Google Scholar
• Bao L, Avshalumov M V, Patel JC, et al. Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling. J Neurosci. 2009;29:9002–10.
   PubMed Web of Science ®Google Scholar
• Sims NR, Anderson MF, Hobbs LM, et al. Impairment of brain mitochondrial function by hydrogen peroxide. Mol Brain Res. 2000;77:176–84.
   PubMedGoogle Scholar
• Miyazaki I, Asanuma M. Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res. 2009;34:698–706.
   PubMed Web of Science ®Google Scholar
• Badillo-Ramírez I, Saniger JM, Rivas-Arancibia S. 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: implications for Parkinson’s disease. Neurochem Int. 2019;129:104514.
   PubMed Web of Science ®Google Scholar
• Dagnino-Subiabre A, Cassels BK, Baez S, et al. Glutathione transferase M2-2 catalyzes conjugation of dopamine and dopa o-quinones. Biochem Biophys Res Commun. 2000;274:32–6.
   PubMed Web of Science ®Google Scholar
• Munoz P, Huenchuguala S, Paris I, et al. Dopamine oxidation and autophagy. Park Dis. 2012;2012.
   PubMed Web of Science ®Google Scholar
• Womersley JS, Townsend DM, Kalivas PW, et al. Targeting redox regulation to treat substance use disorder using N-acetylcysteine. Eur J Neurosci. 2019;50:2538–51.
   PubMed Web of Science ®Google Scholar
• Hongpaisan J, Winters CA, Andrews SB. Strong calcium entry activates mitochondrial superoxide generation, upregulating kinase signaling in hippocampal neurons. J Neurosci. 2004;24:10878–87.
   PubMed Web of Science ®Google Scholar
• Kim HY, Lee KY, Lu Y, et al. Mitochondrial Ca2+ uptake is essential for synaptic plasticity in pain. J Neurosci. 2011;31:12982–91.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Usachev YM. Mitochondrial Ca2+ cycling facilitates activation of the transcription factor NFAT in sensory neurons. J Neurosci. 2009;29:12101–14.
   PubMed Web of Science ®Google Scholar
• Jang EY, Ryu Y, Lee BH, et al. Involvement of reactive oxygen species in cocaine-taking behaviors in rats. Addict Biol. 2015;20:663–75.
   PubMed Web of Science ®Google Scholar
• Beiser T, Yaka R. The role of oxidative stress in cocaine addiction. J Neurol Neuromedicine. 2019;4.
   Google Scholar
• Bu Q, Lv L, Yan G, et al. NMR-based metabonomic in hippocampus, nucleus accumbens and prefrontal cortex of methamphetamine-sensitized rats. Neurotoxicology. 2013;36:17–23.
   PubMed Web of Science ®Google Scholar
• Kita T, Matsunari Y, Saraya T, et al. Methamphetamine-induced striatal dopamine release, behavior changes and neurotoxicity in BALB/c mice. Int J Dev Neurosci. 2000;18:521–30.
   PubMed Web of Science ®Google Scholar
• Lord KC, Shenouda SK, McIlwain E, et al. Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction. Cardiovasc Res. 2010;87:111–8.
   PubMed Web of Science ®Google Scholar
• Cadet JL, Sheng P, All S, et al. Rapid communication: attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem. 1994;62:380–3.
   PubMed Web of Science ®Google Scholar
• Huang MC, Lin SK, Chen CH, et al. Oxidative stress status in recently abstinent methamphetamine abusers. Psychiatry Clin Neurosci. 2013;67:92–100. doi:10.1111/pcn.12025.
   PubMed Web of Science ®Google Scholar
• Jayanthi S, Ladenheim B, Cadet JL. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann N Y Acad Sci. 1998;844:92–102.
   Web of Science ®Google Scholar
• Meng X, Zhang C, Guo Y, et al. TBHQ attenuates neurotoxicity induced by methamphetamine in the VTA through the Nrf2/HO-1 and PI3K/AKT signaling pathways. Oxid Med Cell Longev. 2020;2020.
   Web of Science ®Google Scholar
• Schattauer SS, Bedini A, Summers F, et al. Reactive oxygen species (ROS) generation is stimulated by opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation. J Biol Chem. 2019;294:16884–96. doi:10.1074/jbc.RA119.009592.
   PubMed Web of Science ®Google Scholar
• Maresca A, Del Dotto V, Capristo M, et al. Dnmt1 mutations leading to neurodegeneration paradoxically reflect on mitochondrial metabolism. Hum Mol Genet. 2020;29:1864–81. doi:10.1093/hmg/ddaa014.
   PubMed Web of Science ®Google Scholar
• Hodgson N, Trivedi M, Muratore C, et al. Soluble oligomers of amyloid-β cause changes in redox state, DNA methylation, and gene transcription by inhibiting EAAT3 mediated cysteine uptake. J Alzheimer’s Dis. 2013;36:197–209.
   PubMed Web of Science ®Google Scholar
• Islam MT. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurol Res. 2017;39:73–82. doi:10.1080/01616412.2016.1251711.
   PubMed Web of Science ®Google Scholar
• Kim Y, Connor JR. The roles of iron and HFE genotype in neurological diseases. Mol Aspects Med. 2020;100867.
   Google Scholar
• Nandar W, Connor JR. Hfe gene variants affect iron in the brain. J Nutr. 2011;141:729S–739S.
   PubMed Web of Science ®Google Scholar
• Ye Q, Trivedi M, Zhang Y, et al. Brain iron loading impairs DNA methylation and alters GABAergic function in mice. FASEB J. 2019;33:2460–71.
   PubMed Web of Science ®Google Scholar
• Roy CN, Blemings KP, Deck KM, et al. Increased IRP1 and IRP2 RNA binding activity accompanies a reduction of the labile iron pool in HFE-expressing cells. J Cell Physiol. 2002;190:218–26.
   PubMed Web of Science ®Google Scholar
• Ersahin M, Toklu HZ, Çetinel Ş, et al. Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms. J Pineal Res. 2009;46:324–32.
   PubMed Web of Science ®Google Scholar
• Chang J, Zhang B, Heath H, et al. Nicotinamide adenine dinucleotide (NAD)–regulated DNA methylation alters CCCTC-binding factor (CTCF)/cohesin binding and transcription at the BDNF locus. Proc Natl Acad Sci. 2010;107:21836–41.
   PubMed Web of Science ®Google Scholar
• Im H-I, Hollander JA, Bali P, et al. Mecp2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nat Neurosci. 2010;13:1120–7.
   PubMed Web of Science ®Google Scholar
• Chen WG, Chang Q, Lin Y, et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 2003;302:885–9.
   PubMed Web of Science ®Google Scholar
• Kietzmann T, Petry A, Shvetsova A, et al. The epigenetic landscape related to reactive oxygen species formation in the cardiovascular system. Br J Pharmacol. 2017;174:1533–54.
   PubMed Web of Science ®Google Scholar
• Eskandari MR, Rahmati M, Khajeamiri AR, et al. A new approach on methamphetamine-induced hepatotoxicity: involvement of mitochondrial dysfunction. Xenobiotica. 2014;44:70–6.
   PubMed Web of Science ®Google Scholar
• Beckhauser TF, Francis-Oliveira J, De Pasquale R. Reactive oxygen species: physiological and physiopathological effects on synaptic plasticity: supplementary issue: brain plasticity and repair. J Exp Neurosci. 2016;10:JEN-S39887.
   Google Scholar
• Cadet JL, Bisagno V. Glial-neuronal ensembles: partners in drug addiction-associated synaptic plasticity. Front Pharmacol. 2014;5:204.
   PubMedGoogle Scholar
• Anier K, Zharkovsky A, Kalda A. S-adenosylmethionine modifies cocaine-induced DNA methylation and increases locomotor sensitization in mice. Int J Neuropsychopharmacol. 2013;16:2053–66.
   PubMed Web of Science ®Google Scholar
• Wu Q, Xia S, Lin J, et al. Effects of the altered activity of δ-opioid receptor on the expression of glutamate transporter type 3 induced by chronic exposure to morphine. J Neurol Sci. 2013;335:174–81.
   PubMed Web of Science ®Google Scholar
• Mavencamp TL, Rhoderick JF, Bridges RJ, et al. Synthesis and preliminary pharmacological evaluation of novel derivatives of L-β-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3. Bioorg Med Chem. 2008;16:7740–8.
   PubMed Web of Science ®Google Scholar
• Spiers JG, Breda C, Robinson S, et al. Drosophila Nrf2/Keap1 mediated redox signaling supports synaptic function and longevity and impacts on circadian activity. Front Mol Neurosci. 2019;12(86).
   PubMedGoogle Scholar
• Morales DX, Grineski SE, Collins TW. 乳鼠心肌提取 HHS Public access. Physiol Behav. 2016;176:139–48. doi:10.1111/ejn.14130.Targeting.
   Google Scholar
• Peterson EC, Gentry WB, Owens SM. Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications. Adv Pharmacol. 2014;69:107–27. doi:10.1016/B978-0-12-420118-7.00003-2.
   PubMedGoogle Scholar
• Andrade C. Sustained-release, extended-release, and other time-release formulations in neuropsychiatry. J Clin Psychiatry. 2015;76:e995–9. doi:10.4088/JCP.15f10219.
   PubMed Web of Science ®Google Scholar
• Sagar V, Atluri VSR, Pilakka-Kanthikeel S, et al. Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse. Mol Brain. 2016;9:1–10.
   PubMed Web of Science ®Google Scholar
• He M, Li Z, Ge Y, et al. Portable upconversion nanoparticles-based paper device for field testing of drug abuse. Anal Chem. 2016;88:1530–4.
   PubMed Web of Science ®Google Scholar